(Press-News.org) Every year, more than 120 million prescriptions are written worldwide for thiazide drugs, a group of salt-lowering medicines used to treat high blood pressure. These drugs are often work very well, and over decades have saved hundreds of thousands of lives.
But in some patients, thiazides are not effective; in others they lower blood pressure for a while and then stop working. The reasons for this have remained a mystery. Now, a new study by researchers at the University of Maryland School of Medicine (UM SOM) has revealed a key mechanism for this failure.
Paul Welling, MD, a professor of physiology at the school, and his post-doctoral fellow, P. Rick Grimm, PhD, found the specific genes and pathways used by the kidneys to compensate for thiazides' activity. The paper was published in the latest issue of the journal Journal of Clinical Investigation. The research was done in conjunction with scientists at Vanderbilt University and Emory University.
"This is the first time we really understand how this process works," said Dr. Welling, an expert on potassium and sodium balance, kidney disease and hypertension. "It's as if the kidney knows that it's losing too much salt and activates mechanisms to retain salt in other ways."
Thiazides work by inhibiting the movement of salt through the kidney, causing the kidneys to expel salt and water. Salt often raises blood pressure by increasing the amount of water in the vascular system; over time, this fluid puts pressure on the heart and blood vessels, and can cause hypertension. The kidney counteracts the drugs' effect by retaining more salt, keeping blood pressure high.
Dr. Welling and his collaborators studied an animal model that was genetically engineered to inhibit salt retention, mimicking the effect of thiazides. Using sophisticated technology to track genetic changes in these animals, they found that nearly 400 key genes change their activity to help regulate how the kidneys handle salt. Once activated, these genes worked together, acting on three different pathways related to salt retention. In short these genes increased the body's ability to hold onto salt, shedding light on how the system can react to thiazides. The interaction of these genes and pathways had not been elucidated in detail before.
The new work has important implications and reveals new possibilities for patients with high blood pressure. Dr. Welling says it may now be possible to begin developing drugs that affect the mechanisms through which the body counteracts thiazides. These drugs might eventually be used alongside thiazides, or might be used on their own.
In addition, the researchers have identified a molecule that increases in the urine when the kidney is working to counteract thiazides. Dr. Welling and his colleagues are now investigating the possibility of using this molecule as a "biomarker," allowing doctors to quickly and easily detect when thiazides won't work, or have stopped working, in a particular patient.
"This new work by Dr. Welling is a powerful example of the strong links between basic research and clinical results," said Dean E. Albert Reece, MD, PhD, MBA, who is also the vice president for Medical Affairs, University of Maryland, and the John Z. and Akiko K. Bowers Distinguished Professor and Dean of the School of Medicine. "Now that we know more about these novel pathways and processes, we can begin to find new ways to help patients with high blood pressure."
INFORMATION:
The research was funded by the National Institute of Diabetes, Digestive and Kidney Diseases of the National Institutes of Health.
About the University of Maryland School of Medicine
The University of Maryland School of Medicine was chartered in 1807 and is the first public medical school in the United States and continues today as an innovative leader in accelerating innovation and discovery in medicine. The School of Medicine is the founding school of the University of Maryland and is an integral part of the 11-campus University System of Maryland. Located on the University of Maryland's Baltimore campus, the School of Medicine works closely with the University of Maryland Medical Center and Medical System to provide a research-intensive, academic and clinically based education. With 43 academic departments, centers and institutes and a faculty of more than 3,000 physicians and research scientists plus more than $400 million in extramural funding, the School is regarded as one of the leading biomedical research institutions in the U.S. with top-tier faculty and programs in cancer, brain science, surgery and transplantation, trauma and emergency medicine, vaccine development and human genomics, among other centers of excellence. The School is not only concerned with the health of the citizens of Maryland and the nation, but also has a global presence, with research and treatment facilities in more than 35 countries around the world.
medschool.umaryland.edu/
Following a first seizure, physicians should discuss with patients whether it is appropriate to prescribe medication to reduce risk of another seizure, according to new guidelines released at the American Academy of Neurology meeting.
The guidelines, which were a collaboration of authors at several North American medical institutions including NYU Langone Medical Center, found adults who experience a first seizure may have risk of another seizure that's greatest within the first two years. Adults with prior neurological trauma, abnormalities on EEGs and imaging may be ...
Access to high-quality medicine is a basic human right, but over four billion people live in countries where many medications are substandard or fake. Marya Lieberman of the Department of Chemistry and Biochemistry at the University of Notre Dame and Abigail Weaver a postdoctoral associate in the University's Department of Civil Engineering and Environmental and Earth Sciences took up the challenge of how people in developing countries could detect low quality antimalarial drugs without expensive equipment and without handling dangerous chemicals.
The solution they ...
MADISON, Wis. -- In a move that could improve the energy storage of everything from portable electronics to electric microgrids, University of Wisconsin-Madison and Brookhaven National Laboratory researchers have developed a novel X-ray imaging technique to visualize and study the electrochemical reactions in lithium-ion rechargeable batteries containing a new type of material, iron fluoride.
"Iron fluoride has the potential to triple the amount of energy a conventional lithium-ion battery can store," says Song Jin, a UW-Madison professor of chemistry and Wisconsin Energy ...
Toronto, CANADA - Imagine living a healthy, normal life without the ability to re-experience in your mind personal events from your past. You have learned details about past episodes from your life and can recite these to family and friends, but you can't mentally travel back in time to imagine yourself in any of them.
Cognitive scientists from Baycrest Health Sciences' Rotman Research Institute in Toronto had a rare opportunity to examine three middle-aged adults (two from the U.S., the other from the U.K.) who essentially live their lives in the "third person" because ...
Tryptophan is an amino acid, one of the building blocks of proteins. It is used extensively to study how proteins change their 3D structure, and also how they interact with other proteins and molecules. This is studied with a fluorescence technique called FRET, which measures the transfer of energy from tryptophan to another molecule. But in some cases, FRET data could be distorted because tryptophan transfers an electron instead of energy. Using a unique spectroscopic technique, scientists at EPFL have now confirmed for the first time that this is indeed the case. The ...
CAMBRIDGE, Mass. (April 20, 2015) - A novel approach that allows real-time imaging of the immune system's response to the presence of tumors--without the need for blood draws or invasive biopsies--offers a potential breakthrough both in diagnostics and in the ability to monitor efficacy of cancer therapies.
The method, developed in the lab of Whitehead Institute Member Hidde Ploegh and reported online this week in the Proceedings of the National Academy of Sciences (PNAS), harnesses the imaging power of positron emission tomography (PET), which is normally used to monitor ...
PHILADELPHIA, April 20, 2015 - New findings hidden within the complex machinery behind the vicious cycle of chronic inflammation and cancer are presented today by researchers from the University of Pittsburgh Cancer Institute, partner with UPMC Cancer Center, at the American Association for Cancer Research (AACR) Annual Meeting in Philadelphia.
The research is funded by the National Institutes of Health (NIH) and Fondazione RiMED, of Palermo, Italy.
Inflammation is an important immune system tool that helps the body rid itself of foreign invaders, such as bacteria. ...
New analysis of world-famous 3.46 billion-year-old rocks by researchers from the University of Bristol, the University of Oxford and UWA (the University of Western Australia) is set to finally resolve a long running evolutionary controversy.
The new research, published this week in Proceedings of the National Academy of Sciences USA, shows that structures once thought to be Earth's oldest microfossils do not compare with younger fossil candidates but have, instead, the character of peculiarly shaped minerals.
In 1993, US scientist Bill Schopf described tiny carbon-rich ...
MADISON, Wis. -- If your home country is historically heterogeneous and you know it, crack a smile.
People who live in countries built on centuries of migration from a wide range of other countries are more emotionally expressive than people in more insular cultures, according to research led by University of Wisconsin-Madison psychology Professor Paula Niedenthal.
The study, published this week in the Proceedings of the National Academy of Sciences, compared several social and demographic variables to the way people describe the rules for displaying emotion in dozens ...
A University of Colorado Boulder and North Carolina State University-led team has produced the first atlas of airborne microbes across the continental U.S., a feat that has implications for better understanding health and disease in humans, animals and crops.
The researchers collected outdoor dust samples from roughly 1,200 homes in all 50 states from both urban and rural areas using a powerful DNA sequencing technique to identify specific bacteria and fungal species. While standard, culture-based surveys are able to detect only a handful of different species, the high-tech ...
